Companies plead guilty to misbranding steroid-containing products as supplements

Companies plead guilty to misbranding steroid-containing products as supplements
Two companies have pleaded guilty to unlawful manufacture and distribution in interstate commerce of drugs misbranded as dietary supplements, following an investigation by the FDA.

DCD, LLC dba Advanced Muscle Science (DCD), and R & D Holdings, LLC dba Culver Concepts, Bradley Asgard, and Bjorklund (R & D Holdings) pled guilty in federal court in Idaho after FDA found the active ingredients in the products were synthetic anabolic steroids, or synthetic chemical clones of anabolic steroids.

According to the plea agreements, DCD, LLC could face a fine of $125,000, and R & D Holdings could pay a $21,000 fine.

According to the Department of Justice​, DCD, LLC and its subsidiary, Advanced Muscle Science, have agreed to implement a testing protocol for its products to ensure future products sold as dietary supplements do not contain synthetic steroids.

R & D Holdings no longer manufactures or distributes supplements or drugs and it agreed not to do so for two years from the date of sentencing - set for January 17, 2012, in Boise before Chief U.S. District Judge B. Lynn Winmill.

The case centers on DCD’s products ‘Dienedrone’ and ‘Liquidrone’, and R&D’s ‘Orafinadrol 50’, ‘Microdrol’ and ‘Methyldrostanolone’.

“The products did not meet the DSHEA legal definition of a dietary supplement, nor did they meet any other definition of food,” ​said the Department of Justice.

Department of Justice documents indicate that the charges were brought in federal court in Idaho because the companies delivered their products to a retail company located in Idaho for further distribution throughout the United States.

Related topics Suppliers

Related news

Follow us

Products

View more

Webinars